A Look at Biogen Inc (BIIB) After 5.0% Gain -- GF Value $191.79 vs Price $209.03

Biogen Is Paying $1 Billion for a Company That Won't Say What It Makes. Here's Why That's Actually Good News for BIIB Investors.

This could be a key move for future growth.

Biogen (BIIB) Stock Jumps on Analyst Upgrade Before Key Alzheimer’s Data Release

Truist upgrades Biogen (BIIB) stock to Buy with $235 target ahead of Alzheimer's drug data. Shares rise 1.3% premarket on positive analyst o

Biogen's Q2 2026 Earnings: What to Expect

Biogena Group Invest Aktie: 500-Millionen-Ziel bis 2030

Biogena will an der Wiener Börse eine Stufe höher steigen. CEO Albert Schmidbauer skizzierte am Montag in einem Interview weitreichende Plän